Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
Go back to Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $4.76 | |||
| Open | $2.15 | 52 Week Low | $1.46 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $2.15 | EPS | $-1.91 | |||
| Volume | 77,117 | |||||
